Bioregenx (BRGX) Total Non-Current Liabilities (2021)
Bioregenx's (BRGX) quarterly Total Non-Current Liabilities came in at $151399.0 in Q4 2021.
Bioregenx (BRGX) Total Non-Current Liabilities (2021) Analysis & Trends
Bioregenx's Total Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $151399.0 for Q4 2021.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $151399.0 in Q4 2021; TTM through Dec 2021 was $151399.0, a N/A change from a year earlier, with the FY2021 full-year figure at $151399.0, changed N/A from the prior year.
- Total Non-Current Liabilities was little changed at $151399.0 in Q4 2021 per BRGX's latest filing.
- Across five years, Total Non-Current Liabilities topped out at $151399.0 in Q4 2021 and bottomed at $151399.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 1.79 Bn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 4.14 Bn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 1.12 Bn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 195.02 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 702.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 1.90 Bn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 163.45 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 10.69 Mn |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 151,399.00 |